company background image
7702 logo

JMSLtd TSE:7702 Stock Report

Last Price

JP¥523.00

Market Cap

JP¥12.8b

7D

-2.2%

1Y

3.2%

Updated

06 Apr, 2024

Data

Company Financials

7702 Stock Overview

JMS Co.,Ltd. fabrica, vende, exporta e importa productos sanitarios y farmacéuticos en Japón, Singapur, Indonesia, China, Filipinas, Corea del Sur e internacionalmente.

7702 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends4/6

JMS Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for JMSLtd
Historical stock prices
Current Share PriceJP¥523.00
52 Week HighJP¥608.00
52 Week LowJP¥489.00
Beta0.27
1 Month Change-0.95%
3 Month Change2.55%
1 Year Change3.16%
3 Year Change-45.69%
5 Year Change-23.54%
Change since IPO-66.39%

Recent News & Updates

JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Mar 04
JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Recent updates

JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Mar 04
JMSLtd's (TSE:7702) Dividend Will Be ¥8.50

Shareholder Returns

7702JP Medical EquipmentJP Market
7D-2.2%-4.8%-2.5%
1Y3.2%13.6%34.7%

Rentabilidad frente al sector: 7702 obtuvo unos resultados inferiores a los del sector JP Medical Equipment , que el año pasado arrojó un rendimiento del 6%.

Rentabilidad vs. Mercado: 7702 obtuvo unos resultados inferiores a los del mercado JP, que fue del 29.7% el año pasado.

Price Volatility

Is 7702's price volatile compared to industry and market?
7702 volatility
7702 Average Weekly Movement2.7%
Medical Equipment Industry Average Movement4.0%
Market Average Movement4.0%
10% most volatile stocks in JP Market8.3%
10% least volatile stocks in JP Market2.2%

Precio estable de las acciones: 7702 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 7702 (2%) se ha mantenido estable durante el año pasado.

About the Company

FoundedEmployeesCEOWebsite
19475,650Ryuji Katsurahttps://www.jms.cc

JMS Co.,Ltd. fabrica, vende, exporta e importa dispositivos médicos y productos farmacéuticos en Japón, Singapur, Indonesia, China, Filipinas, Corea del Sur e internacionalmente. La empresa ofrece soluciones de infusión y nutrición, que incluyen puerto de acceso innecesario, sistema cerrado de mezcla e infusión de fármacos, bomba de infusión y sistema de nutrición oral y enteral para tratamiento y pruebas de laboratorio; y soluciones de diálisis, que incluyen equipo de diálisis para hemodiálisis, solución de diálisis peritoneal y equipo APD que realiza automáticamente la inyección y descarga de solución de diálisis peritoneal.

JMS Co.,Ltd. Fundamentals Summary

How do JMSLtd's earnings and revenue compare to its market cap?
7702 fundamental statistics
Market capJP¥12.80b
Earnings (TTM)JP¥204.00m
Revenue (TTM)JP¥64.86b

62.8x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7702 income statement (TTM)
RevenueJP¥64.86b
Cost of RevenueJP¥50.32b
Gross ProfitJP¥14.54b
Other ExpensesJP¥14.33b
EarningsJP¥204.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)8.33
Gross Margin22.41%
Net Profit Margin0.31%
Debt/Equity Ratio59.0%

How did 7702 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

306%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.